New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
60 Degrees Pharmaceuticals, Inc.
SXTP
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

3M

Biotechnology

Next Earning date - 07 Apr 2025

3M

Biotechnology

Next Earning date - 07 Apr 2025

2.12USD

Shape-0.13 ( -5.78%)
moonAfter-hours 2.31$arrow-right-up0.20 (9.20%)
Market Closed (as of Feb 24, 21:00 EDT)
favorite-chart

Relative Strenght

95
favorite-chart

Volume Buzz

-90%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

94%
OverviewChart

Quote Panel

Shape
Updated March 13, 2025
1W 11.54 % 1M -41.22 % 3M -76.95 % 1Y -88.16 %

Key Metrics

Shape

  • Market Cap

    2.58M

  • Shares Outstanding

    1.47M

  • Share in Float

    1.18M

  • Dividende

    0

  • Earning Date

    07 Apr 2025

  • Price Target

    1.75

  • Average Volume

    487502

  • Beta

    4.5407166

  • Range

    1.41-36

  • Industry

    Biotechnology

  • Website

    https://60degreespharma.com

  • Sector

    Healthcare

Fundamentals

Shape

Relative Strength

Shape

SXTP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2M

Shape1304%

2025-Revenue

$3.59

Shape-308%

2025-EPS

$1M

Shape33%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.35
vs -0.23

Q1.23

arrow
arrow

N/A

-0.47
vs -0.16

Q2.23

arrow
arrow

N/A

-1.40
vs -0.39

Q3.23

arrow
arrow

N/A

-18.01
vs -0.26

Q4.23

arrow
arrow

N/A

-0.34
vs -0.35

Q1.24

arrow
arrow

N/A

-26.41
vs -0.47

Q2.24

arrow
arrow

N/A

-21.15
vs -1.40

Q3.24

arrow
arrow

N/A

-4.65
vs -18.01

Q4.24

arrow
arrow

N/A

-4.01
vs -0.34

Q1.25

arrow
arrow

N/A

-2.81
vs -26.41

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-357%

-75652.00  vs 29.5K

Q1.23

arrow
arrow

-63%

17.2K  vs 47K

Q2.23

arrow
arrow

+32%

59.5K  vs 45.2K

Q3.23

arrow
arrow

-70%

51.2K  vs 168.2K

Q4.23

arrow
arrow

+156%

42.7K  vs -75652

Q1.24

arrow
arrow

+751%

146.1K  vs 17.2K

Q2.24

arrow
arrow

+111%

125.7K  vs 59.5K

Q3.24

arrow
arrow

+164%

135.3K  vs 51.2K

Q4.24

arrow
arrow

+485%

250K  vs 42.7K

Q1.25

arrow
arrow

+105%

300K  vs 146.1K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+8%

0.08
vs 0.07

Q1.23

arrow
arrow

+14%

0.14
vs 0.08

Q2.23

arrow
arrow

+15%

0.15
vs 0.14

Q3.23

arrow
arrow

+64%

0.64
vs 0.15

Q4.23

arrow
arrow

-40%

-0.40
vs 0.64

Q1.24

arrow
arrow

+6%

0.06
vs -0.40

Q2.24

arrow
arrow

-137%

-1.37
vs 0.06

Q3.24

arrow
arrow

-36%

-0.36
vs -1.37

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

SXTP

accessnewswire.com

9 hours ago

60 Degrees Pharmaceuticals and Fathom Holdings Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
SXTP

globenewswire.com

9 hours ago

60 Degrees Pharma Announces $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
SXTP

globenewswire.com

10 hours ago

60 Degrees Pharmaceuticals, Inc. Announces 1:5 Reverse Stock Split
SXTP

globenewswire.com

12 hours ago

Sixty Degrees Pharmaceuticals to Ensure Continuity of Tafenoquine Supply in U.S. by Importing Limited Quantity of KODATEF®
SXTP

globenewswire.com

14 hours ago

60 Degrees Pharma Announces Closing of $1.075 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
SXTP

globenewswire.com

14 hours ago

60 Degrees Pharma Announces Closing of $1.043 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules